Sign in and upgrade to a paid plan to export announcements as CSV.

Anthem Biosciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ANTHEM BSE: 544449

About Anthem Biosciences Limited

No company profile on record yet.

Key facts

BSE symbol544449
NSE symbolANTHEM
ISININE0CZ201020
CINL24233KA2006PLC039703
Listing date21 Jul 2025
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorM/s BMP & Co. LLP. (Biswajit Ghosh)
Registered officeNo. 49, F1 & F2, Canara Bank Road Bommasandra Industrial Area, Phase I, Bommasandra

Financial performance

Full financials →
Fiscal yearMar 26
Total income (before exceptional items)2,271†
Net profit671

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
AJAY BHARDWAJExecutive DirectorJune 30, 2026
GANESH SAMBASIVAMExecutive DirectorJune 30, 2026
K RAVINDRA CHANDRAPPAExecutive DirectorJune 30, 2026
RAMESH RAMADURAIIndependent DirectorJune 30, 2026
RAVIKANT UPPALIndependent DirectorJune 30, 2026
SHUBHA KULKARNIIndependent DirectorJune 30, 2026
SUBRAMANIAN MADHAVANIndependent DirectorJune 30, 2026
SATISH CHANDER SUBBANNANon-Executive Director,Nominee DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.